Study #2018-0540
Randomized Phase II Trial to Evaluate Alisertib Alone or Combined with Fulvestrant for Women with Advanced, Endocrine-resistant Breast Cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Meghan Karuturi
Department:
Breast Medical Oncology
For general questions about clinical trials:
1-855-401-1031
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.